2025 HCPCS Code G0472
Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
TAGS: hepatitis individual antibody covered| Short Description | Hep c screen high risk/other |
| Product Note | 0199 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | June 02, 2014 |
| HCPCS Action Effective Date | January 01, 2016 |
| HCPCS Pricing Indicator Code | 13 - Price established by carriers (e.G., not otherwise classified, individual determination, carrier discretion) |
| HCPCS Type Of Service Code | 5 - Diagnostic laboratory |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number | 220 - General immunology - - - |
Check Similar HCPCS Codes
- G9035 - Oseltamivir phosp, brand
- G9036 - Rimantadine hcl, brand
- G9037 - Intrpro req fr rec phys/qhcp
- G9038 - Co-management services
- G9050 - Oncology work-up evaluation
- G9051 - Oncology tx decision-mgmt
- G9052 - Onc surveillance for disease
- G9053 - Onc expectant management pt
- G9054 - Onc supervision palliative
- G9055 - Onc visit unspecified nos
- G9056 - Onc prac mgmt adheres guide
- G9057 - Onc pract mgmt differs trial
- G9058 - Onc prac mgmt disagree w/gui
- G9059 - Onc prac mgmt pt opt alterna
- G9060 - Onc prac mgmt dif pt comorb
- G9061 - Onc prac cond noadd by guide
- G9062 - Onc prac guide differs nos
- G9063 - Onc dx nsclc stgi no progres
- G9064 - Onc dx nsclc stg2 no progres
- G9065 - Onc dx nsclc stg3a no progre